88IV - PR Newswire Asia's news - Biotechnology

< Previous page

| Title only | Print

Next page >

Therakos Receives MDR Approval in Europe for Treating Immune-Related Adverse Events in Patients with Inadequate Response to Corticosteroids DUBLIN , Oct. 22, 2026 /PRNewswire/ -- Therakos Development Limited, a global pioneer in immunomodulatory therapy delivered at the bedside through extracorporeal photopheresis (ECP), announced today ... 2026-10-22T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
Geneos Therapeutics Initiates IMPACT31 Phase 2 Randomized Clinical Trial Evaluating Neoantigen-Targeted Personalized DNA Immunotherapy for Cancer The study evaluates patients with liver cancer at high risk of recurrence following surgical resection Julie Rosenberg, MD, appointed to leadership team as Chief Medical Officer PHILADELPHIA ... 2026-10-21T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
Akeso Announces Summit Therapeutics and ECOG-ACRIN Cancer Research Group Enter into Phase II/III Clinical Trial Collaboration to Evaluate Ivonescimab in First-Line Biliary Tract Cancer Becomes the 7th International Registrational Clinical Trial for Ivonescimab Clinical Trial Site Activations in the United States Expected to Begin Q4 2026 HONG KONG , Oct. 21, 2026 /PRNewswire/ ... 2026-10-21T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
ESTEVE CDMO expands its presence in Asia with a major investment and new manufacturing site in China After more than two decades in China, ESTEVE CDMO marks a new chapter in its commitment to the country and the region. With more than $80 million invested, the new facility brings a new generation ... 2026-10-21T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Chen Qiyu: Building on "Affordability & Reliability", Fosun Expands the Global Reach of Chinese Innovative Drugs HONG KONG , Oct. 21, 2026 /PRNewswire/ -- On 20 October, the Sustainability Global Leaders Conference 2026 was held in Shanghai. The Conference, themed "Building a Resilient Future Together: ... 2026-10-21T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
CSL appoints Deborah Waterhouse as CEO & Managing Director MELBOURNE, Australia , Oct. 21, 2026 /PRNewswire/ -- The Board of Directors of CSL Limited (ASX:CSL; USOTC:CSLLY) today announces that it has appointed Deborah Waterhouse as Chief Executive Officer ... 2026-10-21T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Samsung Biologics Reports Third Quarter 2026 Financial Results Recorded Q3'26 revenue of KRW 1,490 billion and operating profit of KRW 640 billion Plant 5 ramp-up and U.S. manufacturing operations contribute to earnings performance Raised 2026 revenue growth ... 2026-10-21T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Hengrui Pharma Previews ESMO Congress 2026: 64 Research Findings Highlight Continued Progress Across Innovative Pipelines to Advance Clinical Value 64 research findings have been accepted, including three Proffered Paper presentations and three Rapid Oral presentations, spanning more than ten areas of oncology and supportive care. More than 10 ... 2026-10-21T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
AROA and Mölnlycke Partner to Expand U.S. Access to Endoform™ Exclusive co-promotion agreement combines AROA's regenerative tissue technology with Mölnlycke's wound care expertise and commercial reach ... 2026-10-21T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
Telix Reports Third Quarter 2026 Financial Performance MELBOURNE, Australia and INDIANAPOLIS , Oct. 21, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") provides a financial update on its commercial and operational ... 2026-10-21T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals

Next page >

88iv | Home | Login

Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer

Copyright (C) 2026

Suntek Computer Systems Limited.

All rights reserved